
    
      Buprenorphine is a synthetic opioid analgesic with over 25 years of international clinical
      experience indicating it to be safe and effective in a variety of therapeutic settings for
      the relief of moderate to severe pain. BTDS is a transdermal system formulation that is
      designed to deliver a consistent and a steady dose of buprenorphine over a 7-day period with
      limited blood concentration fluctuation.
    
  